Defective metabolism leading to fat maldistribution in patients infected with HIV. The etiology appears to be multifactorial and probably involves some combination of infection-induced alterations in metabolism, direct effects of antiretroviral therapy, and patient-related factors.
Also Known As:
HIV Lipodystrophy Syndrome; HIV-Associated Lipodystrophy; Lipodystrophy Syndrome, HIV; HIV Associated Lipodystrophy; HIV Associated Lipodystrophy Syndrome; Lipodystrophy Syndrome, HIV-Associated; Lipodystrophy, HIV-Associated